Chronic bronchitis is associated with worse symptoms and quality of life than chronic airflow obstruction

Chest

Volumn 148, Issue 2, 2015, Pages 408-416

  Meek, Paula M ^a   Petersen, Hans ^b   Washko, George R ^c   Diaz, Alejandro A ^c   Kim, Victor ^d   Sood, Akshay ^e   Tesfaigzi, Yohannes ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC BRONCHITIS; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; DEPENDENT VARIABLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMOTION; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SMOKING; SOCIAL ASPECT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY; WELLBEING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DAILY LIFE ACTIVITY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; BRONCHITIS, CHRONIC; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84939230553     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-2240     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012; 61 (46): 938-943.
2. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology . R espir Care. 2003; 48 (12): 1185-1191.
3. Kim V, Han MK, Vance GB, et al; COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011; 140 (3): 626-633.
4. Allen-Ramey FC, Gupta S, DiBonaventura MD. Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes. Int J Chron Obstruct Pulmon Dis. 2012; 7: 779-787.
5. Kim V, Davey A, Comellas AP, et al; COPDGene® Investigators. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res. 2014; 15: 52.1-52.9.
6. Martinez CH, Kim V, Chen Y, et al; COPDGene Investigators. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014; 108 (3): 491-499.
7. Murray JF, Mason RJ. M urray and Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Saunders/Elsevier; 2010.
8. Sood A, Stidley CA, Picchi MA, et al. Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers. COPD. 2008; 5 (5): 274-281.
9. Bruse S, Sood A, Petersen H, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med. 2011; 184 (11): 1254-1260.
10. Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J. 2008; 32 (3): 545-554.
11. Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol. 2008; 122 (3): 507-511.
12. Tantisira KG, Litonjua AA, Weiss ST, Fuhlbrigge AL; Childhood Asthma Management Program Research Group. Association of body mass with pulmonary function in the Childhood Asthma Management Program (CAMP). Thorax. 2003; 58 (12): 1036-1041.
13. Sutherland ER, Ellison MC, Kraft M, Martin RJ. Altered pituitary-adrenal interaction in nocturnal asthma. J Allergy Clin Immunol. 2003; 112 (1): 52-57.
14. Wenzel SE, Busse WW; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol. 2007; 119 (1): 14-21.
15. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978; 118 (6 pt 2): 1-120.
16. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145 (6): 1321-1327.
17. Hankinson JL, Oderantz JR, Fedman KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159 (1): 179-187.
18. Magnsson S, Gislason T. Chronic bronchitis in Icelandic males: prevalence, sleep disturbances and quality of life. Scand J Prim Health Care. 1999; 17(2): 100-104.
19. Ioachimescu OC, Teodorescu M. Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology. 2013; 18 (3): 421-431.
20. Jones PW, Anderson JA, Calverley PM, et al; TORCH investigators. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res. 2011; 12: 71.1-71.8.
21. GOLD. Global initiative for chronic obstructive lung disease (GOLD): global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www. goldcopd.org/Guidelines/guidelinesresources. html. Published 2014. Accessed September 5, 2014.
22. Vestbo J, Hurd SS, Agust AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187 (4): 347-365.
23. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006.